金世龙,黄中荣,陈华,等.HuH7细胞系CD13+CD133+HCC细胞分选及CSCs特性分析[J].第三军医大学学报,2012,34(16):1658. Jin Shilong,Huang Zhongrong,Chen Hua,et al.Sorting and cancer stem cell characteristic analysis of CD13+CD133+HCC cells in HuH7 cell line[J].J Third Mil Med Univ,2012,34(02):1658. [2]金世龙,余天雾,黄中荣,等.As2O3在HuH7及CD13+CD133+LCSCs增殖和分化中作用的初步观察[J].第三军医大学学报,2012,34(18):1857. Jin Shilong,Yu Tianwu,Huang Zhongrong,et al.Role of arsenic trioxide in proliferation of HuH7 cells and differentiation of CD13+CD133+ LCSCs[J].J Third Mil Med Univ,2012,34(02):1857. [3]庞林宾,王洪林,王晔飞,等.JAK2/STAT3通路在肝癌细胞侵袭及血管生成拟态中的作用[J].第三军医大学学报,2012,34(18):1862. Pang Linbin,Wang Honglin,Wang Yefei,et al.Role JAK2/STAT3 signaling pathway in invasion and vascular mimicry of liver cancer cells[J].J Third Mil Med Univ,2012,34(02):1862. [4]吴国明,钱桂生.晚期非小细胞肺癌EGFR-TKIs治疗的耐药机制研究――挑战中蕴含新的曙光[J].第三军医大学学报,2012,34(20):2031. Wu Guoming,Qian Guisheng.Drug resistance of epidermal growth factor receptor-tyrosine kinase inhibitors in treatment of advanced non-small cell lung cancer―A new dawn in challenge[J].J Third Mil Med Univ,2012,34(02):2031. [5]祝冰晶,王宇亮,罗虎,等.CA916798基因通过PI3K/AKT通路参与肺癌顺铂耐药[J].第三军医大学学报,2013,35(07):618. Zhu Bingjing,Wang Yuliang,Luo Hu,et al.CA916798 gene is involved in cisplatin resistance in human lung cancer through PI3K/AKT pathway[J].J Third Mil Med Univ,2013,35(02):618. [6]熊震,汤旭东,房殿春,等.人肝素酶RNAi序列的筛选及鉴定[J].第三军医大学学报,2007,29(20):1929. XIONG Zhen,TANG Xu-dong,FANG Dian-chun,et al.Screening and identification of heparanase RNAi sequence[J].J Third Mil Med Univ,2007,29(02):1929. [7]周艳,姜军,张毅,等.雌激素受体β及其剪切变异体表达与雌激素受体阻滞剂治疗耐药的关系[J].第三军医大学学报,2007,29(20):1999. ZHOU Yan,JIANG Jun,ZHANG Yi,et al.Relationship of estrogen receptor-beta and its isoform expressions with tamoxifen resistance in human breast cancer[J].J Third Mil Med Univ,2007,29(02):1999. [8]林辉,刘洁,陈林,等.重庆市2003-2006年肺结核病耐药情况分析[J].第三军医大学学报,2008,30(12):1183. LIN Hui,LIU Jie,CHEN Lin,et al.Drug resistance of tuberculosis from 2003 to 2006 in Chongqing[J].J Third Mil Med Univ,2008,30(02):1183. [9]郑继军,王阁,邓婧,等.PD98059对肝癌HepG2细胞Tec信号转导作用的初步研究[J].第三军医大学学报,2006,28(02):136. [10]郑继军,王阁.肝癌粘附转移中相关整合素的作用研究现状[J].第三军医大学学报,2006,28(02):176. [11]房殿亮,陈伟庆.p15基因干扰对肝癌耐药的影响[J].第三军医大学学报,2011,33(16):1695. Fang Dianliang,Chen Weiqing.Influence of siRNA-mediated p15 silencing on CDDP resistance in drug-resistant human hepatoma cell line HepG2/CDDP/2.0[J].J Third Mil Med Univ,2011,33(02):1695. [12]郭元红,陈伟庆,房殿亮.Runx3基因对HepG2细胞顺铂耐药性的影响[J].第三军医大学学报,2012,34(09):813. Guo Yuanhong,Chen Weiqing,Fang Dianliang.Runx3 improves chemosensitivity of hepatocellular carcinoma cells HepG2 to cisplatin[J].J Third Mil Med Univ,2012,34(02):813.
